Clinical Trial Update: CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating circulating tumor DNA to guide adjuvant therapy decisions in patients with resected stage II colon cancer; status is recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Patients With Resected Stage II Colon Cancer | Phase 3 | Status: RECRUITING